Quality Comes First COUNTRIES CONTACT US EN ABOUT US KEY AREAS INNOVATION & RESEARCH PARTNERING RESPONSIBILITY NEWS & MORE CAREERS Elacestrant for metastatic breast cancer The first oral SERD with positive topline results in pivotal study for the treatment of ER+/HER- breast cancer READ MORE EXPLORE OUR AREAS PHARMACEUTICALS Quality comes first CONSUMER HEALTHCARE Quality & Innovation are the drivers of our Consumer Healthcare activities INNOVATION & RESEARCH Committed to making a difference to the lives of patients ADVANCED DIAGNOSTICS Rare cells analysis to find solutions tailored to each patient’s need PROFESSIONAL DIAGNOSTICS The human touch of technology > DERMATOLOGY AND AESTHETIC MEDICINE RELIFE. My skin says how I feel Latest News 2021 - 11 - 4 Menarini Receives FDA Orphan Drug Designation for SEL24/MEN1703, a first in class, dual PIM/FLT3 inhibitor for the Treatment of Acute Myeloid Leukemia Florence (Italy) November 4th, 2021 – The Menarini Group announced today that the U.S. Food and Drug Administration (FDA) granted orphan drug designation (ODD) to SEL24/MEN1703 for... READ MORE 2021 - 10 - 20 Menarini Group and Radius Health Announce Positive Phase 3 Topline Results from the EMERALD Trial Evaluating Elacestrant in Breast Cancer Florence, Italy and Boston, Mass., October 20, 2021 – the Menarini Group (“Menarini”) and Radius Health, Inc. (“Radius”) (NASDAQ: RDUS) (collectively, the... READ MORE 2021 - 10 - 19 Serie A: the Volpi Rosse Menarini are ready to meet the challenge On 23 October, the first wheelchair basketball team in Tuscany will take part in the Serie A of the National Championship of the FIPIC (Italian Wheelchair Basketball Federation). The... READ MORE SEARCH MENARINI IN THE WORLD Search your country 92 23 52 17 Map Satellite Keyboard shortcuts Map data ©2021 Terms of Use MAIN LOCATIONS MANUFACTURING SITES RESEARCH CENTERS LOCAL OFFICES DISTRIBUTORS Use the key combination "ctrl" + "mouse wheel" or the "+" and "-" buttons at the bottom right to browse the map MENARINI FOR PEOPLE Discover our responsibility projects to stand close to people READ MORE FOLLOW OUR BLOG Discover our stories from all over the world READ MORE FONDAZIONE INTERNAZIONALE MENARINI a meeting point for all friends with common ideals towards the progress of sciences for the benefit of mankind. sergio gorini, foundation’s first president READ MORE Contact Us Terms and conditions Data Privacy Sitemap Pharmacovigilance Cookie Setting Follow Us A.Menarini Industrie Farmaceutiche Riunite S.r.l. VAT number and registration number in the Company House: 00395270481 Office of the Companies House: Florence Share Capital: € 150.000.0000 I.V. © 2021 The Menarini Group - All rights reserved SHARE ON Facebook Twitter SCROLL TO TOP Our website uses cookies, including third party cookies. In addition to Strictly necessary cookies that are essential to browse the website, the site features Functional cookies that ensure you make the most of your browsing experience, Performance cookies, that perform aggregate statistics on the website usage, as well as Targeting cookies that automatically tailor on-line ads on the preferences you expressed while browsing this or other websites. Should you wish to receive more information click on the Cookie Policy. To inhibit Functional cookies, Performance cookies, Targeting cookies and/or cookies of specific third parties click on MORE OPTIONS. By clicking I ACCEPT you will be accepting all the mentioned types of cookies. I ACCEPT MORE OPTIONS